Mizuho raised the firm’s price target on Inspire Medical to $380 from $300 and keeps a Buy rating on the shares. The analyst updated medtech and diagnostics price targets ahead of the Q2 reporting season.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on INSP:
- Inspire Medical price target raised to $350 from $300 at Stifel
- Inspire Medical Systems, Inc. to Report Second Quarter 2023 Financial Results on August 1, 2023
- Inspire Medical price target raised to $355 from $310 at BofA
- Inspire Medical Systems, Inc. Announces FDA Approval for Apnea Hypopnea Index Indication Expansion and Increased Body Mass Index Labeling